title: Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
abstract: We report a case of a 27-year-old man diagnosed with the infection of HBV delta in the 8th month of life. The treatment complied with evidence-based medical guidelines, comprising neoadiuvant chemotherapy and surgery. Liver transplantation from a deceased donor followed by chemotherapy was performed when the patient was 16 years 9 months of age because of recurrent HCC tumor. The patient qualified for immunosuppressive treatment (rapamycin, tacrolimus), lamivudine, anti-HBs globulin intravascular infusion, and anti-HBV vaccination as a prophylaxis against reinfection with HBV. In conclusion, this case demonstrates the importance of a postoperative follow-up of patients with HCC, even years after liver transplantation.
authors: Department of Surgical and Transplantation Nursing, Warsaw Medical University, Warsaw, Poland. Electronic address: wasiakdar@poczta.onet.pl.
authors: D
authors: D
authors: Wasiak
authors: Department of General and Transplantation Surgery, Warsaw Medical University, Warsaw, Poland.
authors: M
authors: M
authors: Jonas
authors: Department of General and Transplantation Surgery, Warsaw Medical University, Warsaw, Poland.
authors: B
authors: B
authors: Łągiewska
authors: Department of Immunology, Transplantology and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
authors: T
authors: T
authors: Cieciura
authors: Department of Surgical and Transplantation Nursing, Warsaw Medical University, Warsaw, Poland.
authors: P
authors: P
authors: Małkowski
authors: Department of General and Transplantation Surgery, Warsaw Medical University, Warsaw, Poland.
authors: A
authors: A
authors: Chmura
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D006509:Hepatitis B / Q000150:complications* / Q000601:surgery; D006515:Hepatitis B virus; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000473:pathology*; D016031:Liver Transplantation; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D012008:Recurrence; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D019259:Lamivudine; D016559:Tacrolimus